Toronto, ON – June 11, 2024 – Copoly is proud to announce that we have been selected to deliver a Startup Showcase talk at Collision 2024, one of the world’s largest and most influential tech conferences, taking place in Toronto from June 17 to June 20, 2024.
Our CEO, Dr. Peng Zhang, will be delivering this highly anticipated presentation on Stage 9 on Thursday, June 20th at 2 PM EST. This prestigious opportunity highlights Copoly’s innovative contributions to cancer diagnostics.
Showcasing Innovation and Impact
Dr. Zhang’s talk will focus on Copoly’s groundbreaking OncoSage technology. OncoSage is a revolutionary blood-based early cancer detection platform that identifies cancer at its most treatable stages.
“We are honored to be selected for a Showcase talk at Collision 2024,” said Dr. Zhang. “This platform allows us to share our vision and innovations with a global audience. OncoSage is at the forefront of cancer detection and research, and we are excited to demonstrate its potential to transform healthcare.”
Engaging with the Tech Community
The Showcase talk will provide attendees with insights into how Copoly’s technologies are making a significant impact in the field of cancer diagnostics. Dr. Zhang will discuss the development and application of OncoSage as well as future directions for research and commercialization.
“Collision 2024 is a gathering of the brightest minds in technology and innovation,” added Dr. Zhang. “We look forward to engaging with industry leaders, investors, and potential partners to explore collaborations that can drive our mission forward. This talk is an excellent opportunity to highlight our progress and the transformative potential of our technologies.”
Join Us at Collision 2024
Copoly invites all attendees of Collision 2024 to attend the Showcase talk by Dr. Peng Zhang. Join us on Stage 9 on Thursday, June 20th at 2 PM EST to learn more about our pioneering work in cancer diagnostics and biomedical research.
For more information or to schedule a meeting with Copoly during Collision 2024, please contact Dr. Peng Zhang.
About Copoly
Copoly is dedicated to advancing cancer diagnostics and biomedical research through innovative technologies. Our flagship product, OncoSage, is a blood-based early cancer detection platform. We strive to improve patient outcomes and accelerate scientific discoveries through cutting-edge solutions.
